Posted On: Sunday, August 9th, 2015
In this issue: The (re)emergence of STIs among MSM: Why does it matter and what can be done? Views from the front lines: Sexually transmitted infections and gay men People living with HIV who are undiagnosed: Revisiting our HIV prevention messaging Does multidisciplinary care improve health outcomes among people living with HIV and/or HCV? A… Read more »
Posted On: Tuesday, August 4th, 2015
A new paper written by researchers from the OHTN, the AIDS Bureau, U of T and St. Michael’s Hospital has shown that community-based HIV prevention programs help avert new infections and save health care dollars. Here are some key findings: From 1987 – 2011, community-based prevention programs averted 16,672 new infections and saved the Ontario… Read more »
Posted On: Monday, July 27th, 2015
In this issue: CATIE News: Hepatitis C treatment program improves access to housing, income and healthcare HIV/Hep C co-infected people with moderate or severe liver injury at risk for liver-related death People co-infected with Hep C and HIV do less well after liver transplantation
Posted On: Sunday, July 26th, 2015
Several studies have found that some people with HIV are more likely to have mental health issues compared to HIV-negative people. Most of these studies have focused on mental health issues such as anxiety and depression. A team of researchers in Denmark has completed a massive study to understand the relationship(s) between schizophrenia, HIV and… Read more »
Posted On: Sunday, July 26th, 2015
Some public health authorities in Canada recommend the routine offer of HIV testing. Routine HIV testing programs in hospitals, family practices, community health centres and other settings may be a strategy to enhance existing HIV testing services. A Vancouver program to train and support family physicians to routinely offer HIV testing… Read more »
Posted On: Sunday, July 26th, 2015
ANTI-HIV AGENTS Changes to DHHS treatment guidelines—new recommendations for initial HIV therapy BONE HEALTH Guidelines for assessing, preventing and treating low bone density in HIV Investigating fracture risk in women with and without HIV Menopause, race/ethnicity and changes in bone density Backbone fractures and HIV A clinical trial of zoledronate for increasing bone density A… Read more »
Posted On: Monday, July 20th, 2015
Vantage Point has produced a resource answering frequently asked questions with respect to changes taking place to the BC Society Act. The eight-page document is available for download here.
Posted On: Monday, July 13th, 2015
In this issue: SHAWNA Project Updates GSHI at CAHR 2015 Women, HIV and the Law Recent Publications
Posted On: Thursday, July 9th, 2015
Posted On: Thursday, July 9th, 2015
by Jason Wong, Physician Epidemiologist, Clinical Prevention Services, BCCDC; and, Linda Hoang, Medical Microbiologist, Laboratory Services, BCCDC; and, Troy Grennan, Medical Head, STI Clinic, Clinical Prevention Services, BCCDC; and, Carolyn Montgomery, Physician Sessional, Clinical Prevention Services, BCCDC; and, Sylvia Makaroff, Physician Sessional, Clinical Prevention Services; BCCDC Background Lymphogranuloma venereum (LGV) is a sexually transmitted infection… Read more »
Posted On: Tuesday, June 30th, 2015
“How are you doing?” For people living with HIV (PLHIV), feeling lonely and isolated is common due to the stigma surrounding the virus—so a simple question like this, asked by someone who knows what you are going through and how to help, can mean a lot. It can also start a connection—to peers who can… Read more »
Posted On: Sunday, June 28th, 2015
New and Noteworthy Daclatasvir receives breakthrough therapy status from the FDA The U.S. Food and Drug Administration (FDA) has granted a breakthrough therapy designation for daclatasvir when used with the already approved medication sofosbuvir (Sovaldi) in people with advanced liver damage. When a medication is designated as a breakthrough therapy the FDA speeds up its… Read more »
